Other drugs can induce AIDs, including immunomodulatory agents used to treat melanoma, such as monoclonal antibodies inhibiting the immune checkpoint pathways, as CTLA4 and programmed cell death protein 1 (PD-1), two-cell surface receptors on T cells which down-regulate immune response (49). Here, PDCD1 is linked to melanoma.